Published in Epilepsia on November 08, 1985
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86
How do seizures stop? Epilepsia (2008) 1.25
Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23
Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Epilepsy Res (2009) 1.17
Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol (1994) 0.99
Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists. J Pharm Sci (1994) 0.96
Gene therapy in epilepsy. Epilepsia (2008) 0.87
Adenosine and adenosine receptors: Newer therapeutic perspective. Indian J Pharmacol (2009) 0.86
Modulators of nucleoside metabolism in the therapy of brain diseases. Curr Top Med Chem (2011) 0.83
2-chloroadenosine attenuates kainic acid-induced toxicity within the rat straitum: relationship to release of glutamate and Ca2+ influx. Br J Pharmacol (1989) 0.81
Adenosinergic signaling in epilepsy. Neuropharmacology (2015) 0.78
A new rapid kindling variant for induction of cortical epileptogenesis in freely moving rats. Front Cell Neurosci (2014) 0.77
Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis. J Neurochem (2017) 0.75
Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish. Zebrafish (2015) 0.75
Chronic Psychosocial Stress and Negative Feedback Inhibition: Enhanced Hippocampal Glucocorticoid Signaling despite Lower Cytoplasmic GR Expression. PLoS One (2016) 0.75
Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission. Br J Pharmacol (1995) 0.75
Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro. Exp Brain Res (1997) 0.75
A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol (1969) 3.89
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Synaptic enhancement in fascia dentata: cooperativity among coactive afferents. Brain Res (1978) 2.53
The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique. Anal Biochem (1968) 2.09
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
Development of epileptic seizures through brain stimulation at low intensity. Nature (1967) 1.73
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev (1998) 1.64
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
Long-term potentiation of the perforant path-granule cell synapse in the rat hippocampus. Brain Res (1975) 1.55
The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol (1991) 1.41
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines. J Physiol (1983) 1.38
Maintenance of long-term potentiation in rat dentate gyrus requires protein synthesis but not messenger RNA synthesis immediately post-tetanization. Neuroscience (1989) 1.37
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26
Asymmetric relationships between homosynaptic long-term potentiation and heterosynaptic long-term depression. Nature (1983) 1.24
CREB phosphorylation promotes nerve cell survival. J Neurochem (1999) 1.24
A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience (1999) 1.22
The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience (2005) 1.21
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res (1995) 1.20
Studies on the nature of the increased monoamine oxidase activity in the rat heart after adrenalectomy. J Pharm Pharmacol (1973) 1.16
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
Inhibitory modulation of long-term potentiation: evidence for a postsynaptic locus of control. Brain Res (1982) 1.09
Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res (1998) 1.09
Vascular reactivity in experimental hypertension. N Z Med J (1968) 1.07
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res (1996) 1.02
Circadian rhythm of synaptic excitability in rat and monkey central nervous system. Science (1977) 1.02
Doublecortin expression in the normal and epileptic adult human brain. Eur J Neurosci (2008) 1.02
Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus. Brain Res (1992) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
The metabolism of tritiated dopamine in regions of the rat brain in vivo. I. The separation of catecholamines and their metabolites. J Neurochem (1969) 1.00
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res Mol Brain Res (1995) 0.99
Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism. J Pharm Pharmacol (1968) 0.99
Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev (1999) 0.99
Long-lasting peripheral and central effects of 6-hydroxydopamine in rats. Br J Pharmacol (1972) 0.98
Commissural inhibition and facilitation of granule cell discharge in fascia dentata. J Comp Neurol (1983) 0.98
Heterosynaptic changes accompany long-term but not short-term potentiation of the perforant path in the anaesthetized rat. J Physiol (1985) 0.98
Field potential evidence for long-term potentiation of feed-forward inhibition in the rat dentate gyrus. Brain Res (1987) 0.97
Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol (1988) 0.97
Changes in brain amine levels associated with the morphological and behavioural development of the worker honeybee. J Comp Physiol A (1992) 0.96
Medial septal facilitation of hippocampal granule cell activity is mediated by inhibition of inhibitory interneurones. Brain Res (1985) 0.96
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study. Neuroscience (1990) 0.96
Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism. Br J Pharmacol (1970) 0.95
Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp Neurol (1969) 0.94
First human hNT neurons patterned on parylene-C/silicon dioxide substrates: Combining an accessible cell line and robust patterning technology for the study of the pathological adult human brain. J Neurosci Methods (2010) 0.93
Neurochemical and morphological changes associated with human epilepsy. Brain Res Brain Res Rev (1995) 0.92
The metabolism of tritiated dopamine in regions of the rat brain in vivo. II. The significance of the neutral metabolites of catecholamines. J Neurochem (1969) 0.92
Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport (1994) 0.91
Loss of Ref-1 protein expression precedes DNA fragmentation in apoptotic neurons. Brain Res Mol Brain Res (1997) 0.91
Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res (1993) 0.91
The mechanisms of action of some antihypertensive drugs. Br Med Bull (1973) 0.90
Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). Neuroscience (2010) 0.90
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience (1993) 0.89
GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience (1990) 0.89
Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett (1990) 0.89
Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res (1997) 0.89
The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain Res Mol Brain Res (1999) 0.88
Catnip and oestrous behaviour in the cat. Anim Behav (1967) 0.88
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. Br J Pharmacol (2010) 0.88
Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res (1996) 0.88
Immediate early gene expression associated with the persistence of heterosynaptic long-term depression in the hippocampus. Proc Natl Acad Sci U S A (1994) 0.88
Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. Eur J Pharmacol (1979) 0.88
Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system. Br J Pharmacol (1969) 0.87
L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharmacol (1989) 0.87
Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res (1994) 0.87
CCAAT-enhancer binding protein alpha is expressed in activated microglial cells after brain injury. Brain Res Mol Brain Res (1998) 0.86
The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Brain Res (1990) 0.86
Differential expression of immediate early genes after hippocampal long-term potentiation in awake rats. Brain Res Mol Brain Res (1993) 0.86
Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel. Neurotoxicology (2007) 0.86
Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol (1997) 0.86
The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain. Eur J Pharmacol (1969) 0.85
High-frequency discharge of dentate granule cells, but not long-term potentiation, induces c-fos protein. Brain Res (1988) 0.84
Annexin V labels apoptotic neurons following hypoxia-ischemia. Neuroreport (1997) 0.84
Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci Lett (2006) 0.84
Induction of Fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized rats. Brain Res Mol Brain Res (1990) 0.84
Immediate early gene transcription and synaptic modulation. J Neurosci Res (1999) 0.84
No change in progenitor cell proliferation in the hippocampus in Huntington's disease. Neuroscience (2011) 0.84
Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation. Neuroscience (1993) 0.84
ATF-2 phosphorylation in apoptotic neuronal death. Brain Res Mol Brain Res (1998) 0.83
Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience (1994) 0.83
Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat central nervous system. Neuroscience (1993) 0.83
Epileptic focus location: spectral analysis method. Science (1970) 0.82
Brief communication. Inability of hexamethonium to block the discriminative stimulus (SD) property of nicotine. Pharmacol Biochem Behav (1978) 0.82
Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations. Arch Neurol (1988) 0.82
3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur J Pharmacol (1991) 0.82
Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist. Neuroreport (1995) 0.82
Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites. Neuroscience (1989) 0.82
Adenosine modulation of amygdala kindling. Exp Neurol (1984) 0.82
Adenosine and seizure termination. Ann Neurol (1991) 0.82
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro. Neuroreport (1999) 0.82
Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience (2005) 0.81
Focal brain injury increases activin betaA mRNA expression in hippocampal neurons. Neuroreport (1997) 0.81
A population of PC12 cells that is initiating apoptosis can be rescued by nerve growth factor. Mol Cell Neurosci (2001) 0.81